[Federal Register Volume 65, Number 163 (Tuesday, August 22, 2000)]
[Notices]
[Page 50994]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-21247]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Joint Meeting of the Pediatric Subcommittee of the Anti-Infective 
Drugs Advisory Committee and the Pediatric Oncology Subcommittee of the 
Oncologic Drugs Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of public advisory 
subcommittees of the Food and Drug Administration (FDA). The meeting 
will be open to the public.
    Name of Committee: The Pediatric Subcommittee of the Anti-Infective 
Drugs Advisory Committee and the Pediatric Oncology Subcommittee of the 
Oncologic Drugs Advisory Committee.
    General Function of the Committees: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on September 12, 2000, 8 
a.m. to 12 noon.
    Location: Hyatt Regency, Baccarat/Haverford Rooms, One Bethesda 
Metro Center, Bethesda, MD.
    Contact Person: Jayne E. Peterson or Karen M. Templeton-Somers, 
Center for Drug Evaluation and Research (HFD-21), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7001, 
or e-mail: at [email protected] or [email protected], or FDA 
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in 
the Washington, DC area), code 12530. Please call the Information Line 
for up-to-date information on this meeting.
    Agenda: The subcommittees will meet jointly to discuss the 
approaches and processes used in pediatric oncology for the development 
of drugs to treat serious and life threatening diseases with limited 
patient populations.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the 
subcommittees. Written submissions may be made to the contact persons 
by September 6, 2000. Oral presentations from the public will be 
scheduled between approximately 10 a.m. and 11 a.m. Time allotted for 
each presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact persons before September 6, 
2000, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation. After the scientific 
presentations, a 30-minute open public session may be conducted for 
interested persons who have submitted their request to speak by 
September 6, 2000, to address issues specific to the topic before the 
subcommittees.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: August 10, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-21247 Filed 8-21-00; 8:45 am]
BILLING CODE 4160-01-F